May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Effects of transfection of matrix metalloproteinase–3 (MMP–3) cDNA on changes of intraocular pressure (IOP) and bleb formation after glaucoma filtering surgery
Author Affiliations & Notes
  • K. Mamiya
    Ophthalmology, Hirosaki Univ Sch of Medicine, Hirosaki, Japan
  • H. Ohguro
    Ophthalmology, Hirosaki Univ Sch of Medicine, Hirosaki, Japan
  • I. Ohguro
    Ophthalmology, Hirosaki Univ Sch of Medicine, Hirosaki, Japan
  • F. Ishikawa
    Ophthalmology, Hirosaki Univ Sch of Medicine, Hirosaki, Japan
  • T. Metoki
    Ophthalmology, Hirosaki Univ Sch of Medicine, Hirosaki, Japan
  • H. Yamazaki
    Ophthalmology, Hirosaki Univ Sch of Medicine, Hirosaki, Japan
  • T. Ito
    Ophthalmology, Hirosaki Univ Sch of Medicine, Hirosaki, Japan
  • M. Nakazawa
    Ophthalmology, Hirosaki Univ Sch of Medicine, Hirosaki, Japan
  • Footnotes
    Commercial Relationships  K. Mamiya, None; H. Ohguro, None; I. Ohguro, None; F. Ishikawa, None; T. Metoki, None; H. Yamazaki, None; T. Ito, None; M. Nakazawa, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 4006. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. Mamiya, H. Ohguro, I. Ohguro, F. Ishikawa, T. Metoki, H. Yamazaki, T. Ito, M. Nakazawa; Effects of transfection of matrix metalloproteinase–3 (MMP–3) cDNA on changes of intraocular pressure (IOP) and bleb formation after glaucoma filtering surgery . Invest. Ophthalmol. Vis. Sci. 2004;45(13):4006.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:To develop gene therapy that can be applied to glaucoma–filtering surgery, we studied effects of transfection of matrix metalloproteinase–3 (MMP–3) cDNA into rabbit conjunctiva by electroporation (EP) on changes of intraocular pressure (IOP) and bleb formation after glaucoma filtering surgery. Methods: pTracer–CMV2 vector containing MMP–3 cDNA was transfected into rabbit conjunctiva by EP and MMP–3 expression was studied by RT–PCR, zymography and western blot analysis. Three days after the transfection of MMP–3 cDNA or vector alone into rabbit conjunctiva, trabeculectomy was performed at the place of transfection in the presence or absence of 0.04% mitomycin C (MMC). Then changes in IOPs and bleb formation were compared with each other. Results:: Expression of MMP–3 was detected in conjunctival epithelium until 30 days after transfection by EP. Trabeculectomy following MMP–3 transfection caused significantly longer survival of filtering bleb and decreased levels of IOP in comparison with controls (trabeculectomy alone or trabeclectomy following vector transfection), and these levels were almost identical to those of trabeculectomy with MMC. Conclusions: The present study indicates that EP is effective to transfect some genes that promote the filtering bleb formation in glaucoma surgery, such as MMP–3 gene, and this may be potentially applicable to glaucoma–filtering surgery in glaucoma patients.

Keywords: gene transfer/gene therapy • extracellular matrix 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×